382 related articles for article (PubMed ID: 26432963)
1. Epigenetics application in the diagnosis and treatment of bladder cancer.
Harb-de la Rosa A; Acker M; Kumar RA; Manoharan M
Can J Urol; 2015 Oct; 22(5):7947-51. PubMed ID: 26432963
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Alterations in Bladder Cancer.
Porten SP
Curr Urol Rep; 2018 Oct; 19(12):102. PubMed ID: 30357502
[TBL] [Abstract][Full Text] [Related]
3. Global epigenetic profiling in bladder cancer.
Dudziec E; Goepel JR; Catto JW
Epigenomics; 2011 Feb; 3(1):35-45. PubMed ID: 22126151
[TBL] [Abstract][Full Text] [Related]
4. Urine epigenomics: a promising path for bladder cancer diagnostics.
Sánchez-Carbayo M
Expert Rev Mol Diagn; 2012 Jun; 12(5):429-32. PubMed ID: 22702358
[No Abstract] [Full Text] [Related]
5. Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Kim YJ; Kim WJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S77-88. PubMed ID: 27326410
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
7. Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Shivakumar M; Lee Y; Bang L; Garg T; Sohn KA; Kim D
BMC Med Genomics; 2017 May; 10(Suppl 1):30. PubMed ID: 28589857
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in prostate cancer.
Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
[TBL] [Abstract][Full Text] [Related]
10. The role of epigenetics in kidney malignancies.
la Rosa AH; Acker M; Swain S; Manoharan M
Cent European J Urol; 2015; 68(2):157-64. PubMed ID: 26251734
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetics of prostate cancer].
Yi XM; Zhou WQ
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):635-41. PubMed ID: 20873600
[TBL] [Abstract][Full Text] [Related]
12. Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.
Oliveira AI; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2012 Nov; 12(8):871-8. PubMed ID: 23249204
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics in Health and Disease.
Zhang L; Lu Q; Chang C
Adv Exp Med Biol; 2020; 1253():3-55. PubMed ID: 32445090
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
16. Feedback networks between microRNAs and epigenetic modifications in urological tumors.
Liep J; Rabien A; Jung K
Epigenetics; 2012 Apr; 7(4):315-25. PubMed ID: 22414795
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics in bladder cancer.
Enokida H; Nakagawa M
Int J Clin Oncol; 2008 Aug; 13(4):298-307. PubMed ID: 18704629
[TBL] [Abstract][Full Text] [Related]
18. Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth.
Cha TL; Chuang MJ; Tang SH; Wu ST; Sun KH; Chen TT; Sun GH; Chang SY; Yu CP; Ho JY; Liu SY; Huang SM; Yu DS
Mol Carcinog; 2015 Mar; 54(3):167-77. PubMed ID: 24115089
[TBL] [Abstract][Full Text] [Related]
19. Potential of histone deacetylase inhibitors for bladder cancer treatment.
Tanji N; Ozawa A; Kikugawa T; Miura N; Sasaki T; Azuma K; Yokoyama M
Expert Rev Anticancer Ther; 2011 Jun; 11(6):959-65. PubMed ID: 21707293
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]